Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype

Nitin Jain, Audrey V. Lamb, Susan O’Brien, Farhad Ravandi, Marina Konopleva, Elias Jabbour, Zhuang Zuo, Jeffrey Jorgensen, Pei Lin, Sherry Pierce, Deborah Thomas, Michael Rytting, Gautam Borthakur, Tapan Kadia, Jorge Cortes, Hagop M. Kantarjian, Joseph D. Khoury

Blood (2016) 127 (15): 1863–1869.

https://doi.org/10.1182/blood-2015-08-661702

Published: 2016

Includes: Supplemental data

Journal Articles

Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Is a High-Risk Subtype in Adults

Nitin Jain, MD, Audrey Lamb, BS, Susan M. O'Brien, MD, Farhad Ravandi, MD, Marina Konopleva, MD PhD, Elias Jabbour, Zhuang Zuo, MD PhD, Jeffrey L. Jorgensen, MD PhD, Pei Lin, MD, Sherry Pierce, BSN, BA, Deborah A Thomas, MD, Michael Rytting, MD, Gautam Borthakur, MD, Tapan Kadia, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Joseph D Khoury, MD

Blood (2015) 126 (23): 1418.

https://doi.org/10.1182/blood.V126.23.1418.1418

Published: 2015

Journal Articles

Incidence of Central Nervous System (CNS) Relapse in De Novo Adult Acute Lymphoblastic Leukemia (ALL)

Blood (2014) 124 (21): 940.

https://doi.org/10.1182/blood.V124.21.940.940

Published: 2014

Journal Articles

Langerhans cell histiocytosis with atypical histiocytic marrow infiltration

Jorge Galvez Silva, Michael Rytting

Blood (2014) 124 (1): 11.

https://doi.org/10.1182/blood-2014-04-563528

Published: 2014

Journal Articles

Incidence and Outcome In Adults With Acute Lymphoblastic Leukemia With Primary Central Nervous System Involvement

Muhamed Baljevic, MD, Hagop M Kantarjian, MD, Deborah Thomas, MD, Michael Rytting, MD, Jyothsna Dasarathula, MBBS, Gautam Borthakur, MD, Jan A. Burger, MD, PhD, Farhad Ravandi, MD, Elias Jabbour, MD, Marina Konopleva, MD, PhD, Sherry Pierce, Mark Brandt, Susan O'Brien, MD, Jorge E. Cortes, MD

Blood (2013) 122 (21): 2639.

https://doi.org/10.1182/blood.V122.21.2639.2639

Published: 2013

Journal Articles

A Phase 1 Study of Dose-Dense 5-Aza-2′-Deoxycitidine (decitabine) in Relapse Refractory Acute Lymphocytic Leukemia (ALL).

Guillermo Garcia-Manero, MD, Deborah Thomas, Michael Rytting, M.D., Patrick A. Zweidler-McKay, MD/PhD, Hui Yang, MD, PhD, Zhihong Fang, Shaoqing Kuang, PhD, Samuel Dara, Susan O'Brien, M.D., Hagop M. Kantarjian, MD

Blood (2009) 114 (22): 2030.

https://doi.org/10.1182/blood.V114.22.2030.2030

Published: 2009

Journal Articles

Augmented Hyper-CVAD in Adult ALL Salvage Therapy: The MDACC Experience of Hyper-CVAD Using Dose-Intense Vincristine, Dexamethasone, and Pegaspargase.

Mohamad Ayoubi, MD, Deborah A. Thomas, MD, Hagop Kantarjian, MD, Susan O'Brien, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Srdan Verstovsek, MD, Michael Rytting, MD, Gautam Borthakur, MD, Tapan Kadia, MD, Steven M. Kornblau, MD, Michael Andreeff, MD, PhD, Jenny Feliu, RN, Stefan Faderl, MD

Blood (2009) 114 (22): 2031.

https://doi.org/10.1182/blood.V114.22.2031.2031

Published: 2009

Journal Articles

Pediatric-Based Therapy for Young Adults with Newly Diagnosed Lymphoblastic Leukemia.

Michael Rytting, M.D., Deborah A. Thomas, MD, Anna R Franklin, Elias Jabbour, William Wierda, MD, PhD, Stefan Faderl, MD, Robert Wells, MD, Tapan Kadia, MD, Farhad Ravandi, M.D., Alessandra Ferrajoli, MD., Jorge Cortes, MD, Susan O'Brien, Hagop Kantarjian, MD

Blood (2009) 114 (22): 2037.

https://doi.org/10.1182/blood.V114.22.2037.2037

Published: 2009

Journal Articles

Outcome for Adolescents and Young Adults (AYA) with the Hyper-CVAD (with or without Rituximab) Regimens for De Novo Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma.

Deborah A. Thomas, MD, Michael Rytting, M.D., Susan O'Brien, MD, Stefan Faderl, MD, William G. Wierda, MD, PhD, Anna Franklin, MD, Rebecca Garris, Farhad Ravandi, MD, Jorge Cortes, MD, Hagop M. Kantarjian, MD

Blood (2009) 114 (22): 3084.

https://doi.org/10.1182/blood.V114.22.3084.3084

Published: 2009

Journal Articles

Durable Remissions Observed in a Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia

Nobuko Hijiya, MD, Paul S. Gaynon, MD, Manuel Fernandez, Lewis B. Silverman, MD, Blythe Thomson, MD, Roland Chu, Todd Cooper, DO, Richard Kadota, MD, Michael Rytting, M.D., Peter G. Steinherz, MD, Violet Shen, Sima Jeha, MD, Elly Barry, MD, William L. Carroll, MD

Blood (2008) 112 (11): 2925.

https://doi.org/10.1182/blood.V112.11.2925.2925

Published: 2008

Journal Articles

Toxicities in Adults with Acute Lymphoblastic Leukemia (ALL) Treated with Regimens Using Pegasparaginase.

Michael Rytting, M.D., Marc Earl, PharmD, Dan Douer, MD, Brenda Muriera, RN, Anjali Advani, MD, Archie Bleyer, MD

Blood (2008) 112 (11): 1924.

https://doi.org/10.1182/blood.V112.11.1924.1924

Published: 2008

Journal Articles

Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) after Frontline Therapy with Hyper-CVAD Regimens.

Deborah A. Thomas, MD, Susan O’Brien, M.D., Michael Rytting, M.D., Stefan Faderl, MD, Jorge Cortes, MD, William G. Wierda, MD, PhD, Farhad Ravandi, MBBS, Hagop M Kantarjian

Blood (2008) 112 (11): 1930.

https://doi.org/10.1182/blood.V112.11.1930.1930

Published: 2008

Journal Articles

Experience with the Combination of a Hypomethylating Agent and Valproic Acid in Pediatric Acute Myelogenous Leukemia

Michael Rytting, M.D., Patrick Zweidler-McKay, M.D., Ph.D., Yang Hui, Hagop Kantarjian, M.D., Guillermo Garcia-Manero, M.D.

Blood (2008) 112 (11): 4036.

https://doi.org/10.1182/blood.V112.11.4036.4036

Published: 2008

Journal Articles

Young Adults with Acute Lymphoblastic Leukemia (ALL) Treated with Adapted Augmented Berlin-Frankfurt-Munster (ABFM) Therapy

Michael Rytting, M.D., Deborah Thomas, M.D., Anna Franklin, M.D., William Wierda, M.D., Stefan Faderl, M.D., Farhad Ravandi, M.D., Brenda Muriera, RN, Hagop M. Kantarjian, MD, Susan O’Brien, M.D.

Blood (2008) 112 (11): 3957.

https://doi.org/10.1182/blood.V112.11.3957.3957

Published: 2008

Journal Articles

Intensification of Hyper-CVAD with L-Asparaginase, Vincristine, and Dexamethasone ("Augmented Hyper-CVAD") Has Activity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL).

Stefan Faderl, MD, Deborah A. Thomas, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Miloslav Beran, MD PhD, Michael Rytting, MD, Charles A. Koller, MD, Srdan Verstovsek, MD PhD, Gautam Borthakur, MD, Michael Andreeff, MD PhD, Steve Kornblau, MD, Susan O’Brien, MD, Khanh Vu, MD, Monica Kwari, RN, Jennie Bretz, RN, Hagop M. Kantarjian, MD

Blood (2007) 110 (11): 4324.

https://doi.org/10.1182/blood.V110.11.4324.4324

Published: 2007

Journal Articles

Adaptation of Augmented Berlin-Frankfurt-Munster (ABFM) Therapy in Adolescents and Young Adults with Acute Lymphoblastic Leukemia (ALL).

Michael Rytting, MD, Deborah Thomas, M.D., Hagop Kantarjian, M.D., Jorge Cortes, M.D., Gautam Borthakur, M.D., William Wierda, M.D., Cesar Nunez, M.D., Steven Kornblau, M.D., Farhad Ravandi, M.D., Robert Wells, M.D., Muriera Brenda, R.N., Franklin Anna, M.D., Susan O’Brien, M.D.

Blood (2007) 110 (11): 4342.

https://doi.org/10.1182/blood.V110.11.4342.4342

Published: 2007

Journal Articles

Minimal Residual Disease (MRD) after Frontline Therapy in Adolescent and Young Adult (AYA) Patients with Acute Lymphoblastic Leukemia (ALL) Treated on Two Separate Regimens.

Michael Rytting, MD, Deborah Thomas, M.D., Jeffrey Jorgensen, M.D., Hagop Kantarjian, M.D., Rebecca Garris, Brenda Muriera, R.N., Susan O’Brien, M.D.

Blood (2007) 110 (11): 4344.

https://doi.org/10.1182/blood.V110.11.4344.4344

Published: 2007

Journal Articles

Intensively Timed Induction (ITI) Chemotherapy in Adults with Acute Myelogenous Leukemia (AML).

Michael Rytting, MD, Srdan Verstovsek, M.D., Ph.D., Guillermo Garcia-Manero, M.D., Farhad Ravandi-Kashani, M.D., Sherry Pierce, R.N., Elihu Estey, M.D.

Blood (2007) 110 (11): 1851.

https://doi.org/10.1182/blood.V110.11.1851.1851

Published: 2007

Journal Articles

Toxicities of Intravenous (IV) Pegasparaginase (ONCASPAR®) in Adults with Acute Lymphoblastic Leukemia (ALL).

Anjali Advani, MD, Marc Earl, PharmD, Dan Douer, MD, Michael Rytting, MD, Archie Bleyer, MD

Blood (2007) 110 (11): 2811.

https://doi.org/10.1182/blood.V110.11.2811.2811

Published: 2007

Journal Articles

Phase I Study of 5-aza-2′-Deoxycitidine, Alone or in Combination with Hyper-CVAD, in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL).

Guillermo Garcia-Manero, MD, Deborah Thomas, MD, Michael Rytting, MD, Patrick Zweidler-McKay, MD, Zeev Estrov, MD, Devri L. Brown, MD, Hui Yang, MD, Hagop Kantarjian, MD, Susan O’Brien, MD

Blood (2007) 110 (11): 2826.

https://doi.org/10.1182/blood.V110.11.2826.2826

Published: 2007

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype

Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Is a High-Risk Subtype in Adults

Incidence of Central Nervous System (CNS) Relapse in De Novo Adult Acute Lymphoblastic Leukemia (ALL)

Langerhans cell histiocytosis with atypical histiocytic marrow infiltration

Incidence and Outcome In Adults With Acute Lymphoblastic Leukemia With Primary Central Nervous System Involvement

A Phase 1 Study of Dose-Dense 5-Aza-2′-Deoxycitidine (decitabine) in Relapse Refractory Acute Lymphocytic Leukemia (ALL).

Augmented Hyper-CVAD in Adult ALL Salvage Therapy: The MDACC Experience of Hyper-CVAD Using Dose-Intense Vincristine, Dexamethasone, and Pegaspargase.

Pediatric-Based Therapy for Young Adults with Newly Diagnosed Lymphoblastic Leukemia.

Outcome for Adolescents and Young Adults (AYA) with the Hyper-CVAD (with or without Rituximab) Regimens for De Novo Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma.

Durable Remissions Observed in a Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia

Toxicities in Adults with Acute Lymphoblastic Leukemia (ALL) Treated with Regimens Using Pegasparaginase.

Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) after Frontline Therapy with Hyper-CVAD Regimens.

Experience with the Combination of a Hypomethylating Agent and Valproic Acid in Pediatric Acute Myelogenous Leukemia

Young Adults with Acute Lymphoblastic Leukemia (ALL) Treated with Adapted Augmented Berlin-Frankfurt-Munster (ABFM) Therapy

Intensification of Hyper-CVAD with L-Asparaginase, Vincristine, and Dexamethasone ("Augmented Hyper-CVAD") Has Activity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL).

Adaptation of Augmented Berlin-Frankfurt-Munster (ABFM) Therapy in Adolescents and Young Adults with Acute Lymphoblastic Leukemia (ALL).

Minimal Residual Disease (MRD) after Frontline Therapy in Adolescent and Young Adult (AYA) Patients with Acute Lymphoblastic Leukemia (ALL) Treated on Two Separate Regimens.

Intensively Timed Induction (ITI) Chemotherapy in Adults with Acute Myelogenous Leukemia (AML).

Toxicities of Intravenous (IV) Pegasparaginase (ONCASPAR®) in Adults with Acute Lymphoblastic Leukemia (ALL).

Phase I Study of 5-aza-2′-Deoxycitidine, Alone or in Combination with Hyper-CVAD, in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only